Effects of long-term oral treatment with selective vasopressin V2 receptor antagonist (OPC-31260) on adriamycin-induced heart failure in rats

2006 ◽  
Vol 108 (2) ◽  
pp. 231-236 ◽  
Author(s):  
Masayuki Takeuchi ◽  
Jong-Dae Lee ◽  
Hiromasa Shimizu ◽  
Takanori Ueda
Keyword(s):  
Heart Failure ◽  
Receptor Antagonist ◽  
Oral Treatment ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

Aquaretic and hormonal effects of a vasopressin V2 receptor antagonist after acute and long-term treatment in rats

2000 ◽  
Vol 394 (1) ◽  
pp. 131-138 ◽  
Author(s):  
Colette Lacour ◽  
Gérard Galindo ◽  
Françoise Canals ◽  
Danielle Segondy ◽  
Catherine Cazaubon ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Term Treatment ◽  
Hormonal Effects ◽  
Vasopressin V2 Receptor ◽  
Long Term Treatment ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

Effect of SR121463, a Selective Non-Peptide Vasopressin V2 Receptor Antagonist, in a Rabbit Model of Ocular Hypertension

2000 ◽  
Vol 16 (3) ◽  
pp. 203-216 ◽  
Author(s):  
FREDERIC LACHERETZ ◽  
ALAIN BARBIER ◽  
CLAUDINE SERRADEIL-LE GAL ◽  
PIERRE-PAUL ELENA ◽  
JEAN-PIERRE MAFFRAND ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Ocular Hypertension ◽  
Rabbit Model ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist
Sign in / Sign up

Export Citation Format

Share Document